Printer Friendly

InforSense(R) Launches HealthSense; Broadens Application Portfolio.

* Delivers next generation of clinical decision support portal to Windber Research Institute and Walter Reed Army Medical Center

* Clinician's Portal to be presented at HIMMS Conference

LONDON & CAMBRIDGE, Mass. -- InforSense Ltd., the leading provider of embedded enterprise analytics, today delivers InforSense HealthSense to the healthcare market. InforSense collaborated with the Windber Research Institute (WRI) to create a workflow-based decision support solution that enables clinicians to easily browse and dynamically drill down into large patient data sets to identify key risk factors for better decision-making in patient care, which has been commercialized within HealthSense. HealthSense is currently in production use at WRI and the Walter Reed Army Medical Center, where it is used in support of the breast cancer research program.

HealthSense, an extension of the InforSense KDE integrative analytics platform, is optimized for clinical data management and analysis, allowing study both at the population and individual patient level. The platform supports relevant clinical data types, and offers an extensive range of analytic methods and intuitive viewers that target the needs of those involved in clinical research. In addition, HealthSense provides a way to intuitively deliver this knowledge to the physician to support treatment decisions.

"It is increasingly recognized by clinicians that leveraging the wealth of information coming from clinical practice, including clinical research, can support better decision-making in patient care," said Dr. Michael Liebman, Director of the Windber Research Institute. "We are proud of the results of our collaboration with InforSense in producing HealthSense, which provides the needed efficient analysis and interpretation of healthcare data."

"InforSense HealthSense is a natural extension of our KDE platform, which is a key technology supporting Life Sciences Research globally," said Dr. Jonathan Sheldon, Chief Scientific Officer of InforSense. "We have now partnered with WRI to release the first analytics platform that supports the entire R&D process from biological target to marketable drug."

InforSense HealthSense provides access to a wide range of analytic components and laboratory data, including gene expression and genetics. Any of the components can be accessed via InforSense workflows to create analytical processes, which are then deployed to the portal for the use at the point of care by the physician.

Witness how the Clinician's Portal is used by clinicians and researchers at WRI: Michael Liebman and Jonathan Sheldon present "Translational Medicine from Basic Research to Enabled Communications" at the HIMMS conference in New Orleans, Louisiana on Monday, February 26, 2007 from 12:30 - 1:30pm. InforSense is also demonstrating HealthSense at HIMMS Booth 2668.

About InforSense KDE

Using InforSense KDE, enterprises rapidly integrate and deliver virtually any data source, analytic software tool, service or application within a single informatics framework. Users link these components via visual workflows to dynamically answer any question using their data, however complex or transient. Organizations can also mine their analytical processes to discover and deploy expertise and best practices. InforSense KDE provides an open, extensible service-oriented architecture, built using industry standards including J2EE, XML, and WSDL. InforSense IOE is a state-of-the-art solution for enterprise-wide integrative analytics using Oracle's advanced information management and processing capabilities. Available extensions to the InforSense KDE platform for different analytical domains include InforSense BioSense for bioinformatics, ChemSense for cheminformatics, GenSense for statistical genetics, HealthSense for clinical decision support, and TextSense for text analytics.

About InforSense

InforSense Ltd., the leader in integrative analytics, enables organizations to orchestrate and optimize their business-critical decision-making processes. Leading pharmaceutical and biotechnology, consumer goods, healthcare, financial services companies, and research institutes are using the company's flagship product, InforSense KDE, to enhance productivity by embedding analytics within their business processes. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.

About Windber Research Institute

The Windber Research Institute is a translational medicine research center that focuses on bringing the problems in the clinic back to the research laboratory for analysis at the genomic, proteomic, image and informatic levels. It is focused in its research areas on women's health, including obstetrics and gynecologic diseases including breast, ovarian, endometrial and cervical cancers, cardiovascular disease, obesity and diabetes, and processes of normal aging including menopause. It has worked closely with its partners at InforSense to develop an integrated research environment that is being extended to support physician decision making in collaboration with the patient.

Windber Research Institute collaborates closely with the Walter Reed Army Medical Center and with the Joyce Murtha Breast Care Center, the University of Pittsburgh Medical Center and Cancer Institute, Georgetown University, and the University of California-San Francisco in the areas of women's health, cardiovascular disease and obesity. It is a private, non-profit research institute that is located approximately 1.5 hours from Pittsburgh, Pennsylvania, in the Laurel Highlands Mountains, and is affiliated with the Windber Medical Center, part of the Conemaugh Healthcare System which services central Pennsylvania. Additional information can be obtained at www.wriwindber.org.

For more information visit www.inforsense.com

InforSense, TextSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 21, 2007
Words:843
Previous Article:ARC Announces Return of Successful ConfigCon(TM) Conference Series With New Locations Added for 2007.
Next Article:Arcelor Mittal Reports Pro Forma Full Year and Fourth Quarter 2006 Results.
Topics:


Related Articles
ADVANSTAR BUYS AUTO TITLES FROM CAHNERS; REALIGNS ADVANSIAR.COM.
CYGNUS ACQUIRES "DESIGN/BUILD BUSINESS" FROM MCKELLAR PUBLICATIONS.
Develop foods for an aging population.
The European Union Commission approves Archer Daniels Midland Co.'s purchase of Unilever NV's edible oil refining subsidiary Van den Bergh.
Develop foods for an aging population.
InforSense Initiates Annual 'Open House': Presentations by Customers, Including GlaxoSmithKline and Windber Research Institute, Showcase ROI for...
Windber Research Institute Extends Collaboration with InforSense(R) to Provide Their Informatics Platform for Translational Medicine Research.
Fujitsu Remains at the Top in Japanese IT Outsourcing Revenue Ranking for Two Consecutive Years.
InforSense(R) Launches GenSense - Statistical Genetics Solution.
AHCA 2006 exhibitor express.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters